Home/Pipeline/VivaZome Stroke Therapy

VivaZome Stroke Therapy

Acute and Chronic Stroke

PreclinicalActive

Key Facts

Indication
Acute and Chronic Stroke
Phase
Preclinical
Status
Active
Company

About Vivazome

Australian exosome biotech targeting TBI, stroke and neurodegeneration with GMP‑scale EV therapeutics.

View full company profile